Related Experiment Video
Updated: Jul 5, 2025
06:59
Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.6K
Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated
Arpanjeet Kaur1, Arshdeep S Dhaliwal2, Sumit Sohal3
1Department of Medicine Icahn School of Medicine at Mount Sinai Morningside/West- New York New York NY.
Journal of the American Heart Association
|January 19, 2024
Summary
Cerebral embolic protection devices (CEPD) did not significantly reduce stroke or improve other outcomes during transcatheter aortic valve replacement, according to a meta-analysis. Further research is needed to clarify their role in TAVR procedures.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Medical Devices
Background:
- Cerebral embolic protection devices (CEPD) aim to prevent ischemic brain injury during transcatheter aortic valve replacement (TAVR).
- Previous studies on CEPD effectiveness during TAVR have yielded mixed results.
- An updated meta-analysis was conducted to evaluate the impact of CEPD on clinical, neurological, and safety outcomes in TAVR.
Conclusions:
- The use of cerebral embolic protection devices (CEPD) during transcatheter aortic valve replacement (TAVR) is not associated with a significant reduction in clinical, neurological, or safety risks.
- Current evidence does not support a routine benefit of CEPD in TAVR procedures based on the analyzed outcomes.
